Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Diabetes Mellitus and SLCO1B1[original query] |
|---|
| Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics 2009 Nov 124 (5): e868-77. Watchko Jon F, Lin Zhili, Clark Reese H, Kelleher Amy S, Walker M Whit, Spitzer Alan R, |
| Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers. European journal of clinical pharmacology 2011 Jul 67 (7): 701-7. He Jiake, Qiu Zhixia, Li Ning, Yu Yang, Lu Yang, Han Deen, Li Tingting, Zhao Di, Sun Wei, Fang Fang, Zheng Jianheng, Fan Hongwei, Chen Xiji |
| Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers. European journal of clinical pharmacology 2013 Mar 69 (3): 407-13. Cheng Yu, Wang Guo, Zhang Wei, Fan Lan, Chen Yao, Zhou Hong-H |
| Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia. Molecular diagnosis & therapy 2013 Oct 17 (5): 299-309. Shabana Mona F, Mishriki Amal A, Issac Marianne Samir M, Bakhoum Sameh W |
| Statin-induced myopathy SLCO1B1 521T?>?C is associated with prediabetes, high body mass index and normal lipid profile in Emirati population. Diabetes research and clinical practice 2018 Mar . Saber-Ayad Maha, Manzoor Shaista, El-Serafi Ahmed, Mahmoud Ibrahim, Abusnana Salah, Sulaiman Nab |
| Effects of ABCG2 and SLCO1B1 gene variants on inflammation markers in patients with hypercholesterolemia and diabetes mellitus treated with rosuvastatin. European journal of clinical pharmacology 2020 May . Zhang Dan, Ding Yangming, Wang Xiaoxue, Xin Wenyu, Du Wenwen, Chen Wenqian, Zhang Xianglin, Li Pengm |
| Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results. European review for medical and pharmacological sciences 2020 Jan 24 (1): 469-477. Licito A, Marotta G, Battaglia M, Benincasa G, Mentone L, Grillo M R, De Lucia V, Leonardi G, Bignucolo A, Comello F, Di Francia R, De Lucia |
| Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients. BMC medical genomics 2021 Jun 14 (1): 156. Song Jin-Fang, Zhang Jie, Zhang Ming-Zhu, Ni Jiang, Wang Tao, Zhao Yi-Qing, Khan Naveed Ull |
| SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico. Tuberculosis (Edinburgh, Scotland) 2022 Sep 136 102248. Perea-Jacobo Ricardo, Muñiz-Salazar Raquel, Laniado-Laborín Rafael, Zenteno-Cuevas Roberto, Cabello-Pasini Alejandro, Ochoa-Terán Adrián, Radilla-Chávez Patric |
| Development of pharmacogenomic algorithm to optimize nateglinide dose for the treatment of type 2 diabetes mellitus. Pharmacological reports : PR 2022 8 74 (5): 1083-1091. Naushad Shaik Mohammad, Hussain Tajamul, Alrokayan Salman A, Kutala Vijay Kum |
| CYP3A and CYP2B6 Genotype Predicts Glucose Metabolism Disorder among HIV Patients on Long-Term Efavirenz-Based ART: A Case-Control Study. Journal of personalized medicine 2022 Jun 12 (7): . Tadesse Wondmagegn Tamiru, Mlugu Eulambius Mathias, Shibeshi Workineh, Degu Wondwossen Amogne, Engidawork Ephrem, Aklillu Ele |
| Transporter Genes and statin-induced Hepatotoxicity. Cardiovascular drugs and therapy 2024 5 . Seo-A Choi, Jung Sun Kim, Yoon-A Park, Da Hoon Lee, Minju Park, Jeong Yee, Yoonkyung Chang, Tae-Jin Song, Hye Sun Gw |
- Page last reviewed:Feb 1, 2024
- Content source: